首页> 外文期刊>Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association >Secondary IGF-I Deficiency as a Prognostic Factor of Growth Hormone (GH) Therapy Effectiveness in Children with Isolated, Non-acquired GH Deficiency
【24h】

Secondary IGF-I Deficiency as a Prognostic Factor of Growth Hormone (GH) Therapy Effectiveness in Children with Isolated, Non-acquired GH Deficiency

机译:继发性IGF-I缺乏症是孤立,未获得性GH缺乏症儿童生长激素(GH)治疗效果的预后因素

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: Growth hormone (GH) deficiency (GHD) has recently been classified as secondary IGF-I deficiency but the significance of IGF-I measurement in diagnosing GHD is still discussed. The aim of the study was to assess the relationships between IGF-I secretion and GH therapy effectiveness in children with GHD.
机译:目的:生长激素(GH)缺乏症(GHD)最近已被列为继发性IGF-I缺乏症,但仍在探讨IGF-I测量在诊断GHD中的意义。该研究的目的是评估GHD儿童的IGF-I分泌与GH治疗效果之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号